Tandem Diabetes Care Inc (TNDM)
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NASDAQ
Market cap: $1.09B
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Latest financial period: June 30, 2026
Filed with the SEC: August 6, 2026
Estimated earnings date: November 5, 2026
Profit #1372 of 1480 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 5.4% | 5.1% | 4.5% | 4.1% |
Growth #1322 of 1480 companies
Payout #1116 of 1480 companies
Safety #1430 of 1480 companies
Price #1399 of 1480 companies
